Record #20857

A Phase-1, 6-Month Open-Label, Dose-Ranging Pharmacokinetic Study in Stabilized Patients with Schizophrenia Following Risperidone Implant

Citation lifecycle

How this paper is being cited

Pre-retraction
0
Same day
0
Post-retraction
2
% post-retraction
100.0%
~0.0 citations/yr before retraction · ~0.2 citations/yr after
citing papers

Who is still citing this work

Loading…